Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Raja Roti Cemerlang Tbk. (BRRC) vs Diagnos Laboratorium Utama Tbk. (DGNS) Price & Performance

Raja Roti Cemerlang Tbk.Trade
Diagnos Laboratorium Utama Tbk.Trade

Price performance (Past 24H)

Key statistics

Raja Roti Cemerlang Tbk. vs Diagnos Laboratorium Utama Tbk. — how do they compare? Raja Roti Cemerlang Tbk. trades at Rp65 (market cap 65.64B, 32.04M 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is far larger — about 4.8× Raja Roti Cemerlang Tbk.'s market cap, and Raja Roti Cemerlang Tbk. is more actively traded (32.04M versus 41.7K). Which is the better fit depends on your goals.

BRRCDGNS
Market Cap
65.64B316.25B
Volume
32.04M41.7K
Lot
320.37K417
Turnover
2.08B9.66M
Average Price
64.81231.65
Value
2.08B9.66M
Indicative Equilibrium Price
65230
Indicative Equilibrium Volume
18.28K2.4K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BRRC
View details
DGNS
View details

About Raja Roti Cemerlang Tbk.

PT Raja Roti Cemerlang Tbk (the Company) was established based on Notarial Deed No. 5 dated September 21, 2015 of Dian Rohmah Yuniasari, S.H., M.Kn., notary in Bekasi. The Company begin its operation activities in 2015.

Read more on BRRC

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS